Cardiovascular disease: application of a composite risk index from the Telehealth System in a district community

Y B Yip1, Thomas K S Wong, Joanne W Y Chung

  • 1Telehealth Team, School of Nursing, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong. hsvyip@inet.polyu.edu.hk

Insights

A new Cardiovascular Disease Risk Index (CVDRI) effectively identifies high-risk individuals in communities. Higher CVDRI scores significantly increase the likelihood of developing cardiovascular disease (CVD), highlighting the need for targeted interventions.

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • Cardiovascular disease (CVD) poses a significant public health challenge.
  • Effective risk stratification is crucial for community-based health interventions.

Purpose of the Study:

  • To develop and validate a composite Cardiovascular Disease Risk Index (CVDRI) using Telehealth System data.
  • To assess the association between the number of CVD risk factors and CVD prevalence in a community setting.

Main Methods:

  • Utilized data from 1,570 residents in Hong Kong's Tsing Yi community.
  • Developed a quantitative CVDRI (0-6 score) incorporating systolic/diastolic blood pressure, diabetes, BMI, smoking, and age.
  • Employed multivariate logistic regression to calculate odds ratios for CVD prevalence.

Main Results:

  • Individuals with CVDRI scores of 1, 2, and 3+ had 1.7, 5.3, and 10 times higher odds of CVD, respectively, compared to a score of 0.
  • High blood pressure was the most influential CVDRI component, followed by diabetes and high BMI.
  • The CVDRI effectively identified individuals at increased risk for cardiovascular disease.

Conclusions:

  • A CVDRI derived from Telehealth data is a practical tool for identifying community members at risk of CVD.
  • Simultaneous management of multiple risk factors in high-risk groups can enhance CVD morbidity and mortality reduction through nurse-led interventions.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...